<DOC>
	<DOCNO>NCT00258453</DOCNO>
	<brief_summary>RATIONALE : Collecting information craniopharyngioma diagnose treat may help doctor predict patient 's response treatment help plan best treatment . It may also help identify intermediate- long-term effect treatment . PURPOSE : This clinical trial collect information diagnosis , treatment , quality life young patient undergo surgery craniopharyngioma .</brief_summary>
	<brief_title>Observation Young Patients Who Are Undergoing Surgery Craniopharyngioma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Identify apply therapy strategy pediatric patient craniopharyngioma . - Correlate relapse status different therapy strategies/modality patient . - Determine health status ( i.e. , ophthalmologic , neuropediatric , endocrine finding ) health-related quality life patient treatment . Secondary - Determine incidence craniopharyngioma pediatric patient . - Identify quality control measure diagnosis therapy patient . - Improve long-term care standardize follow-up program patient . - Determine efficacy endocrine substitution postoperative hypopituitarism patient . - Identify risk factor develop obesity correlate neurotransmitter concentration leptin neuropeptide Y cerebral spinal fluid , serum , craniopharyngioma cystic fluid likelihood develop obesity patient . - Determine incidence extent eat disorder patient . OUTLINE : This multicenter study . Patients undergo neurologic , endocrine , ophthalmologic test anthropometric diagnostic measurement . Patients undergo 1 follow surgical procedure : total resection ; incomplete , subtotal , partial resection ; biopsy ; cyst pressure release . Patients whose tumor relapse may undergo second resection and/or radiotherapy . Quality life assess baseline periodically thereafter . After surgery , patient follow periodically . PROJECTED ACCRUAL : A total 120 patient accrue study .</detailed_description>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Craniopharyngioma</mesh_term>
	<mesh_term>Adamantinoma</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis primary craniopharyngioma MRI CT scan ( initial diagnosis ) Patients cystic sellar parasellar malformation ( e.g. , Rathke pouch cyst suprasellar cyst ) allow undergo observation PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>perioperative/postoperative complication</keyword>
	<keyword>weight change</keyword>
	<keyword>childhood craniopharyngioma</keyword>
</DOC>